S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
LON:CREO

Creo Medical (CREO) Share Forecast, Price & News

GBX 100
0.00 (0.00%)
(As of 05/13/2022 12:00 AM ET)
Add
Compare
Today's Range
97
100
50-Day Range
98.10
125
52-Week Range
96.80
219.81
Volume
50,378 shs
Average Volume
124,332 shs
Market Capitalization
£181.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive CREO News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical and its competitors with MarketBeat's FREE daily newsletter.

Creo Medical logo

About Creo Medical

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
217
Year Founded
N/A

Sales & Book Value

Annual Sales
£9.43 million
Cash Flow
GBX 28.60 per share
Book Value
GBX 39.80 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£181.01 million
Optionable
Not Optionable

Company Calendar

Last Earnings
9/23/2020
Today
5/15/2022
Next Earnings (Estimated)
6/02/2022

MarketRank

Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Creo Medical (LON:CREO) Frequently Asked Questions

When is Creo Medical's next earnings date?

Creo Medical is scheduled to release its next quarterly earnings announcement on Thursday, June 2nd 2022.
View our earnings forecast for Creo Medical
.

How were Creo Medical's earnings last quarter?

Creo Medical Limited (LON:CREO) announced its quarterly earnings results on Wednesday, September, 23rd. The company reported ($6.00) earnings per share (EPS) for the quarter.
View Creo Medical's earnings history
.

Who are Creo Medical's key executives?
Creo Medical's management team includes the following people:
  • Mr. Craig Jonathan Gulliford, CEO & Exec. Director (Age 51, Pay $796.88k)
  • Prof. Christopher Paul Hancock, Founder, CTO & Exec. Director (Age 54, Pay $607.1k)
  • Mr. Richard John Rees ACA, CFO, Company Sec. & Exec. Director (Age 45, Pay $606.73k)
  • Mr. David Gerard Woods, Chief Commercial Officer & Exec. Director (Age 56, Pay $397.73k)
  • Mr. Phil Hales, Sales & Marketing Director
What other stocks do shareholders of Creo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Creo Medical investors own include MySQUAR (MYSQ) and IQE (IQE).

What is Creo Medical's stock symbol?

Creo Medical trades on the London Stock Exchange (LON) under the ticker symbol "CREO."

How do I buy shares of Creo Medical?

Shares of CREO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Creo Medical's stock price today?

One share of CREO stock can currently be purchased for approximately GBX 100.

How much money does Creo Medical make?

Creo Medical has a market capitalization of £181.01 million and generates £9.43 million in revenue each year.

How many employees does Creo Medical have?

Creo Medical employs 217 workers across the globe.

What is Creo Medical's official website?

The official website for Creo Medical is creomedical.com.

How can I contact Creo Medical?

The company can be reached via phone at +44-1291-606005.

This page was last updated on 5/15/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.